Gordon Cameron Obe Email & Phone Number

Cambridge, Cambridgeshire, United Kingdom

Scotland, GB

Specialty Pharma business, pursuing an organic and a buy-and-build growth strategy in UK and Europe. Backed by healthcare-focussed PE investors, Apposite Capital.

Hartley Wintney, Hampshire, GB

Pharmaceutical Development Organisation, providing clinical trial, regulatory, pharmacovigilance and related services to pharma and biotech clients worldwide. Backed by private equity firm, LDC

Leading independent co-educational day and boarding school in Cambridge for boys and girls aged 4-13

Nottingham, Nottinghamshire, GB

Part of MBO backed by Bridgepoint Development Capital in 2013. Secondary buy out backed by GHO Capital in 2015, followed by further buy out backed by Permira Capital Advisors in 2019. Led the acquisitions of five businesses over that period, and the associated funding.Quotient Sciences is a hybrid CRO: CDMO with a unique approach to drug development.

Nottingham, Nottinghamshire, GB

As Group CFO, led M&A buy-and-build strategy, fund-raising, debt refinancing and overall financial strategy across the Quotient Bioresearch group of companies. PE-backed by TA Associates. Completed eight acquisitions and four disposals, the final one of which was the sale of Quotient Clinical to Bridgepoint Devpt Capital

Joined as CFO, leading M&A and fund-raisings. Appointed as President of Acambis, Inc. followng acquisition of US-based company. Moved to, and lived in, Boston, MA for five years. During that time, Acambis won and executed on $500m+ US Government contracts, and grew from 60 to 250+ employees, and became one of the few profitable biotechnology companies.

Paris, France, FR

Advised wide variety of plc and private companies on M&A, fund-raising, restructurings, IPO and disposals.

Advised wide variety of plc and private companies on M&A, fund-raising, restructurings, IPO and disposals.

London, GB

Ma (Hons), Economics

Education record